Lower Anti-Mullerian Hormone is Associated with Lower Oocyte Yield but not Live-Birth Rate among Women with Obesity.
Anti-Mullerian hormone is produced by small antral follicles and reflects ovarian reserve. Obesity is associated with lower serum anti-Mullerian hormone but it is unclear whether lower levels of anti-Mullerian hormone in women with obesity reflects lower ovarian reserve. To determine whether lower Anti-Mullerian hormone in women with obesity undergoing in vitro fertilization is associated with oocyte yield and live-birth rate. Retrospective cohort from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database of 13316 women with obesity and 16579 women with normal BMI undergoing their first autologous IVF with fresh transfers between 2012 and 2014. Normal BMI was defined as BMI 18.5-24.9 kg/m2, obesity was defined as BMI ≥30 kg/m2 and subjects with obesity were stratified as Class 1 obesity (BMI 30.0-34.9 kg/m2), Class 2 obesity (BMI 35.0-39.9 kg/m2) and Class 3 obesity (BMI ≥40 kg/m2) based on the World Health Organization BMI guidelines. Anti-Mullerian hormone levels were stratified as normal (>1.1 ng/ml), low (0.16-1.1 ng/ml) and undetectable (≤ 0.16 ng/ml). Multivariable modeling was used to assess oocyte yield using linear regression with a logarithmic transformation and odds of live birth using logistic regression. Women with obesity were older (36.0 ± 4.8 vs. 35.5 ± 4.8, P<0.001), had lower Anti-Mullerian hormone (1.8 ± 2.0 ng/ml vs. 2.1 ± 2.0 ng/ml, P<0.001) and fewer oocytes retrieved (11.9 ± 7.3 vs. 12.8 ± 7.7, P<0.001) than women with normal BMI. Lower oocyte yield was observed among women with obesity and normal Anti-Mullerian hormone levels compared to women with normal BMI and normal Anti-Mullerian hormone levels (13.6 ± 7.3 vs. 15.8 ± 8.1, P<0.001). No difference in oocyte yield was observed among women with obesity and low Anti-Mullerian hormone levels (P=0.58) and undetectable Anti-Mullerian hormone (P=0.11) compared to women with normal BMI and similar Anti-Mullerian hormone levels. Among women with a BMI ≥30 kg/m2, Anti-Mullerian hormone levels were associated with the number of oocytes retrieved (β=0.069, SE=0.005, p<0.001) but not live birth rates (OR 0.98, 95% CI 0.93-1.04, p=0.57). Lower Anti-Mullerian hormone in infertile women with obesity appears to reflect lower ovarian reserve as Anti-Mullerian hormone is associated with lower oocyte yield. Despite lower oocyte yield, lower Anti-Mullerian hormone was not associated with lower live birth rate among women with obesity.